查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018780

生物安全检测产品与服务市场：2026-2032年全球市场预测，依产品、检测方法、技术、最终用途及服务类型划分

Biological Safety Testing Products & Services Market by Product, Test, Technology, End Use, Service Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物安全检测产品和服务市场价值将达到 69.8 亿美元，到 2026 年将成长至 77.8 亿美元，到 2032 年将达到 149.8 亿美元，复合年增长率为 11.51%。

主要市场统计数据
基准年 2025 69.8亿美元
预计年份：2026年 77.8亿美元
预测年份 2032 149.8亿美元
复合年增长率 (%) 11.51%

全面概述现代生物安全检测的优先事项以及影响实验室和生产韧性的战略驱动因素。

生物安全检测正逐渐成为科学研究、临床和生产领域机构的核心策略。随着监管要求日益严格，相关人员对产品完整性的审查也愈发严格，实验室负责人和品管团队必须部署能够可靠检测污染风险，并能无缝融入更快产品开发週期的检测系统。同时，技术和分析技术的进步正在重新定义检测的可能性，以实现更灵敏、自动化和高通量的检测方法，从而减少停机时间并确保持续合规。

技术创新、更严格的监管和供应链重组如何影响生物安全检测的营运模式？

生物安全检测领域正经历快速变革，这主要归因于技术创新、数位融合以及监管机构对产品安全性的日益重视。新型分析平台和改进的检测化学技术提高了灵敏度和特异性，重塑了检测方法的选择和验证流程。同时，实验室自动化和工作流程最佳化平台提高了处理能力和可重复性，减少了人为因素的影响，并加快了决策週期。

评估近期美国关税变化对生物安全检测供应链和筹资策略的营运和采购影响。

美国近期实施的关税措施为从全球供应商采购设备、试剂和专用零件的企业带来了新的挑战。这些贸易干预措施提高了某些进口商品的接收成本，迫使采购者重新评估供应商选择标准、库存缓衝和总拥有成本 (TCO) 的计算，从而影响采购决策。从营运角度来看，这些成本压力促使企业探索在地采购，并与供应商就价值工程解决方案展开更深入的对话。

高解析度細項分析揭示了产品、测试方法、技术、最终用途和服务模式的交汇领域，从而形成需求模式。

了解市场需要多角度的观点，将技术要求与使用者需求结合。基于产品细分，市场被分为四大类：「仪器」、「试剂和试剂盒」、「服务和软体」。仪器又细分为生物安全柜、ELISA 仪器和 PCR 仪器等类别。试剂和试剂盒包括培养基、ELISA 试剂和试剂盒以及 PCR 试剂和试剂盒。服务包括校准服务、咨询服务和验证服务。软体包括资料管理软体和工作流程自动化软体。这些产品细分揭示了资本投资、耗材成本和持续服务合约的集中方向，有助于确定哪些供应商的能力对不同的使用者群体最有价值。

对美洲、欧洲、中东和非洲以及亚太地区的需求驱动因素、监管差异和供应状况进行区域分析，以指南策略定位。

区域差异在决定生物安全检测的优先顺序方面起着至关重要的作用。在美洲，先进的製造地、严格的监管要求以及成熟的服务供应商生态系统共同推动了需求成长。这种环境鼓励对自动化、验证服务和资料管理平台进行投资，以支援合规性和规模化生产。同时，在欧洲、中东和非洲（EMEA）地区，监管协调的努力和各国不同的框架使得适应性和完善的文件记录至关重要，当地的专业服务提供者通常与全球供应商合作，以提供符合合规性的解决方案。

对企业策略、伙伴关係以及产品/服务整合如何决定生物安全检测领域的竞争优势进行了深入的评估。

生物安全检测生态系统中的主要企业透过整合技术深度、法规专业知识和广泛的服务范围来脱颖而出。一些公司专注于创新先进的计量仪器和耗材，大力投资于检测性能和稳定性，以满足受监管行业的需求。其他市场参与企业则优先考虑卓越的服务，提供校准、验证和咨询服务包，以降低客户采用门槛并加快监管核准。越来越多的公司也专注于软体和数据解决方案，使检查室能够整合测试数据、自动化工作流程并在检查期间证明数据的完整性。

透过有系统地实施自动化、资料完整性实务和弹性筹资策略来加强试点专案的实用领导指南。

领导者应优先考虑那些既能提升短期营运效率又能促进持续能力建构的投资。关键措施包括加快采用快速自动化检测方法，这些方法能够在降低风险和缩短週期时间的同时，确保符合监管要求。对资料管理和工作流程自动化的配对投资将透过提高可追溯性、减少人为错误以及缩短品质和合规团队的审核週期，进一步放大这些优势。同时，加强与供应商的关係并采用多元化采购策略，可以降低贸易中断带来的风险，并保障关键试剂和组件供应链的持续性。

对技术和商业性见解所依据的多源研究途径、验证实践和分析框架进行透明的解释。

本分析结合了一手和二手研究，旨在全面掌握测试方法的技术细节以及影响采购和服务模式的商业性因素。一手资料包括对检查室经理、品质专家、采购负责人和服务供应商的访谈，从中深入了解验证挑战、供应商动态和营运重点。二手资料包括公开的监管指南、技术白皮书、供应商资料和行业报告，这些资料提供了测试方法的性能特征和技术比较资讯。

最终整合策略重点，强调对技术、验证和供应弹性进行全面投资，以提高测试的可靠性。

总之，生物安全检测领域瞬息万变，各机构必须采取综合方法，兼顾技术卓越、法规应对力、营运韧性。仪器、试剂和软体的进步为提高检测灵敏度和流程效率提供了重要机会，但要实现这些目标，需要严谨的验证，确保资料完整性，并符合监管要求。在采购和供应链趋势不断变化的背景下，积极主动地实现供应商多元化和服务伙伴关係，可以降低风险，并维持关键检测能力的连续性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生物安全检测产品与服务市场：依产品类别划分

  • 装置
    • 生物安全柜
    • ELISA装置
    • PCR装置
  • 试剂和试剂盒
    • 培养基
    • ELISA试剂和试剂盒
    • PCR试剂和试剂盒
  • 服务
    • 校对服务
    • 咨询服务
    • 验证服务
  • 软体
    • 资料管理软体
    • 工作流程自动化软体

第九章：依检测类型分類的生物安全检测产品与服务市场

  • 微生物附着量
    • 平板计数
    • 快速方法
  • 内毒素
    • LAL考试
    • rFC 测试
  • 微生物鑑定
    • MALDI-TOF
    • 基于PCR的
  • 无菌
    • 直接接种
    • 薄膜过滤

第十章：生物安全检测产品与服务市场：依技术划分

  • 层析法
  • ELISA
  • 质谱分析
  • PCR

第十一章：生物安全检测产品与服务市场：依最终用途划分

  • 学术研究和调查
  • 生物技术
  • CRO
  • 食品/饮料
  • 医院/诊断
  • 製药

第十二章：按服务类型分類的生物安全检测产品与服务市场

  • 内部实施
  • 外包

第十三章：生物安全侦测产品与服务市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：生物安全检测产品与服务市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：生物安全检测产品与服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国生物安全检测产品与服务市场

第十七章：中国生物安全检测产品与服务市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Asahi Kasei Corporation
  • Avance Biosciences Inc.
  • BBF Sterilisationsservice GmbH
  • BSL Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Eurofins Scientific SE
  • Labquality Oy
  • Lonza Group AG
  • Merck KGaA
  • North American Science Associates, Inc.
  • NuAire, Inc.
  • Pace Analytical Services, LLC
  • Samsung Biologics
  • Sartorius AG
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • UL LLC
  • ViruSure GmbH
  • WuXi Biologics Co., Ltd.
Product Code: MRR-A866040826BE

The Biological Safety Testing Products & Services Market was valued at USD 6.98 billion in 2025 and is projected to grow to USD 7.78 billion in 2026, with a CAGR of 11.51%, reaching USD 14.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.98 billion
Estimated Year [2026] USD 7.78 billion
Forecast Year [2032] USD 14.98 billion
CAGR (%) 11.51%

Comprehensive orientation to contemporary biological safety testing priorities and strategic enablers shaping laboratory and manufacturing resilience

Biological safety testing has emerged as a strategic backbone for organizations operating in research, clinical and manufacturing environments. As regulatory expectations tighten and stakeholder scrutiny of product integrity increases, laboratory leaders and quality teams are under pressure to adopt testing regimens that reliably detect contamination risks while integrating seamlessly into faster product development cycles. In parallel, advances in technology and analytics are redefining what is possible, enabling more sensitive, automated, and high-throughput approaches that reduce downtime and support consistent compliance.

This report synthesizes current industry dynamics as they pertain to instruments, consumables, services, and software frameworks that collectively constitute biological safety testing capabilities. It also examines the implications for laboratories and manufacturers as they navigate a shifting regulatory landscape, evolving supply chains, and new commercial models for testing services. The objective is to provide strategic readers with a clear line of sight into the operational levers that can improve safety outcomes, lower risk exposure, and enhance the resilience of testing programs.

Throughout this document, attention is given to both the technical considerations-such as method selection, validation rigor, and data integrity-and the organizational enablers including workforce skills, vendor partnerships, and digital integration. This integrated view supports executives and technical leaders in prioritizing investments that deliver measurable improvements in testing reliability and regulatory confidence.

How converging technological innovation, regulatory tightening, and supply chain reorientation are reshaping biological safety testing operational models

The landscape of biological safety testing is undergoing rapid transformation driven by converging forces: technological innovation, digital integration, and heightened regulatory focus on product safety. New analytical platforms and enhanced assay chemistries are raising the bar for sensitivity and specificity, which in turn reshapes method selection and validation pathways. Simultaneously, laboratory automation and workflow orchestration platforms are enabling higher throughput and reproducibility, reducing manual variability and accelerating decision cycles.

Regulatory authorities are recalibrating expectations around data integrity, traceability, and risk-based testing strategies, prompting organizations to adopt more robust quality systems and stronger documentation practices. As regulators emphasize lifecycle assurance, firms must invest in controls that demonstrate consistent performance across manufacturing scales and supply chain partners. This regulatory tightening favors solutions that provide auditable data trails and interoperability with laboratory information management systems.

Supply chain dynamics are also shifting, influencing procurement and risk management strategies for critical test consumables and instruments. Organizations are responding by diversifying supplier bases, pursuing strategic long-term agreements, and embracing service models that mitigate inventory and calibration burden. Taken together, these trends are prompting laboratories to rethink their operating models, prioritize digital and technical upgrades, and cultivate partnerships that accelerate safe, compliant, and efficient testing outcomes.

Evaluating the operational and procurement consequences of recent United States tariff changes on biological safety testing supply chains and sourcing strategies

Recent tariff measures implemented in the United States have introduced a new layer of complexity for organizations that source instruments, reagents, and specialized components from global suppliers. These trade interventions have influenced procurement decisions by increasing landed costs for certain imported goods, which in turn has prompted buyers to re-evaluate vendor selection criteria, inventory buffers, and total cost of ownership calculations. From an operational standpoint, such cost pressures have encouraged firms to explore local sourcing alternatives and increase dialogue with suppliers around value-engineered solutions.

In practice, the impact of tariff changes extends beyond immediate cost adjustments. Organizations have adapted by revisiting contractual terms, incorporating flexibility in supply agreements, and accelerating qualification of alternative suppliers to reduce exposure. Procurement teams are employing scenario-based analyses to quantify the operational implications of ongoing tariff volatility, while quality leaders continue to emphasize equivalency and validation pathways for alternative products. These adaptive behaviors support continuity of testing operations and maintain compliance while organizations navigate a more uncertain trade environment.

Moreover, the tariff environment has reinforced the appeal of service-based models, where calibration, validation, and other technical functions can be outsourced to geographically diversified partners. By shifting certain operational responsibilities to service providers, organizations can reduce capital outlays and benefit from more predictable operating costs. In summary, recent tariff developments have catalyzed strategic shifts in sourcing philosophy, inventory management, and partnership design across the biological safety testing ecosystem.

High-resolution segmentation analysis revealing where product, test method, technology, end use, and service mode converge to shape demand patterns

Understanding the market requires a multi-dimensional view that aligns technical requirements with user needs. Based on product segmentation, the market is studied across Instruments, Reagents & Kits, Services, and Software; Instruments are further examined through categories including Biosafety Cabinets, ELISA Instruments, and PCR Instruments; Reagents & Kits include Culture Media, ELISA Reagents & Kits, and PCR Reagents & Kits; Services encompass Calibration Services, Consulting Services, and Validation Services; and Software incorporates Data Management Software and Workflow Automation Software. These product distinctions reveal where capital expenditure, consumable spend, and recurring service commitments concentrate, and they help identify which vendor capabilities are most valuable to different user cohorts.

Examining the market by test reveals differentiated operational and methodological imperatives. Based on test segmentation, the market is studied across Bioburden, Endotoxin, Microbial Identification, and Sterility; Bioburden testing is further distinguished by Plate Count and Rapid Methods; Endotoxin testing is categorized into LAL Test and rFC Test; Microbial Identification covers MALDI-TOF and PCRBased approaches; and Sterility testing includes Direct Inoculation and Membrane Filtration. These distinctions clarify where investments in rapid methods and high-sensitivity platforms yield the greatest operational benefit and where traditional methods remain indispensable for regulatory acceptance.

The technology dimension further illuminates the technical trade-offs organizations face. Based on technology segmentation, the market is studied across Chromatography, ELISA, Mass Spectrometry, and PCR, each offering distinct performance characteristics, throughput profiles, and validation complexities. In turn, the end use segmentation highlights who demands these solutions and how procurement priorities differ across application contexts. Based on end use segmentation, the market is studied across Academic & Research, Biotechnology, CRO, Food & Beverage, Hospitals & Diagnostics, and Pharmaceutical. These end users prioritize different combinations of throughput, sensitivity, regulatory readiness, and total cost.

Service mode adds a final layer of operational differentiation. Based on service mode segmentation, the market is studied across In House and Outsourced. Organizations electing in-house delivery often do so for greater control and ownership of methods, while those opting to outsource prioritize operational flexibility and access to specialized capabilities. Synthesizing across these segmentation lenses provides a roadmap for product development, commercial positioning, and customer support models that align technical capabilities with the nuanced needs of varied end users.

Region-specific analysis of demand drivers, regulatory variances, and supply realities across Americas, EMEA, and APAC that inform strategic positioning

Regional variation plays a central role in shaping priorities for biological safety testing. In the Americas, demand is driven by a combination of advanced manufacturing footprints, stringent regulatory expectations, and a mature service provider ecosystem. This environment encourages investments in automation, validation services, and data management platforms that support compliance and scale. Meanwhile, in Europe, Middle East & Africa, regulatory harmonization efforts and diverse national frameworks create a landscape where adaptability and strong documentation practices are critical, and where specialized local providers often partner with global vendors to deliver compliant solutions.

The Asia-Pacific region presents a different set of dynamics characterized by rapid capacity expansion in manufacturing and research, a growing middle-market for clinical diagnostics, and varying regulatory maturity across countries. Organizations operating in Asia-Pacific frequently prioritize cost-efficiency alongside scalable testing workflows, and they often pursue hybrid models that blend local sourcing with global technology partnerships. Across regions, supply chain considerations, tariff impacts, and access to trained personnel shape the tactical choices that laboratories and manufacturers make when selecting instruments, reagents, and service models.

Taken together, these geographic perspectives underscore the importance of tailoring commercial and technical approaches for regional realities. Companies that align product portfolios and support models with regional regulatory and operational requirements are better positioned to capture demand and build resilient partnerships.

Insightful assessment of how corporate strategies, partnerships, and product-service integration define competitive advantage in biological safety testing

Leading companies in the biological safety testing ecosystem differentiate through a combination of technical depth, regulatory expertise, and service breadth. Some firms concentrate on advanced instrumentation and consumable innovation, investing heavily in assay performance and ruggedization to meet the needs of regulated industries. Other market participants emphasize service excellence, offering calibration, validation, and consulting packages that reduce adoption friction and accelerate regulatory acceptance for customers. There is also a growing cohort that focuses on software and data solutions, enabling laboratories to unify testing data, automate workflows, and demonstrate data integrity during inspections.

Strategic partnerships and channel models are common, as companies seek to extend their reach and localize support services. Distribution networks, certification programs, and training offerings are key enablers of customer success, particularly in regions with emerging regulatory frameworks. Mergers and acquisitions have historically been a mechanism to acquire complementary capabilities, accelerate time to market for integrated solutions, and consolidate technical expertise. Overall, successful firms balance product innovation with strong service delivery and scalable commercial models that address the operational realities faced by laboratory and manufacturing customers.

Practical leadership guidance to fortify testing programs through methodical adoption of automation, data integrity practices, and resilient sourcing strategies

Leaders should prioritize investments that deliver both short-term operational improvements and durable capability upgrades. Key actions include accelerating the adoption of rapid and automated testing modalities where they demonstrably reduce risk or cycle time while maintaining regulatory defensibility. Complementary investments in data management and workflow automation will amplify these benefits by improving traceability, reducing manual errors, and enabling faster review cycles for quality and compliance teams. In parallel, stronger supplier relationship management and multi-sourcing strategies will reduce vulnerability to trade disruptions and support continuity of critical reagent and component supply.

Operationally, it is important to develop clear validation roadmaps that expedite qualification of alternative products and methods when procurement dynamics change. Investing in cross-functional training enhances resilience by broadening internal capability to adapt methods and interpret complex data. Finally, consider service partnerships for non-core functions such as specialized calibration and validation to free internal teams to focus on strategic priorities. These approaches collectively reduce risk, enhance agility, and create measurable improvements in testing throughput and compliance readiness.

Transparent explanation of the multi-source research approach, validation practices, and analytical frameworks underpinning the technical and commercial findings

This analysis draws on a mix of primary and secondary research tailored to capture both the technical nuances of testing methods and the commercial considerations that shape procurement and service models. Primary inputs include interviews with laboratory leaders, quality specialists, procurement professionals, and service providers, eliciting insights on validation challenges, supplier dynamics, and operational priorities. Secondary inputs encompass published regulatory guidelines, technical whitepapers, vendor documentation, and industry reports that inform method performance characteristics and technology comparisons.

Analytically, findings were synthesized using a cross-sectional framework that maps product and technology capabilities to test requirements and end user needs. Validation methods included triangulation across interviews and documented specifications, and where appropriate, scenario analysis to assess how tariff and supply chain shifts might influence sourcing decisions. Quality controls for the research process included expert review cycles and sensitivity checks to ensure interpretations are robust and actionable for decision-makers operating in regulated environments.

Final synthesis of strategic priorities emphasizing integrated investments in technology, validation, and supply resilience to elevate testing reliability

In closing, the evolving landscape of biological safety testing requires organizations to adopt a holistic approach that balances technical excellence, regulatory readiness, and operational resilience. Advances in instruments, reagents, and software offer substantial opportunities to improve detection sensitivity and process efficiency, but realizing these gains depends on careful validation, data integrity practices, and alignment with regulatory expectations. As procurement and supply chain dynamics shift, a proactive approach to supplier diversification and service partnerships can mitigate risk and preserve continuity of critical testing capabilities.

Ultimately, leaders who combine targeted technology investments with stronger data governance, robust validation roadmaps, and adaptive sourcing strategies will be best positioned to maintain compliance while accelerating product and process timelines. The resulting capability improvements not only reduce safety risk but also enable organizations to scale more efficiently and respond to regulatory inquiry with confidence. These integrated steps form the foundation for a resilient and future-ready approach to biological safety testing.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Safety Testing Products & Services Market, by Product

  • 8.1. Instruments
    • 8.1.1. Biosafety Cabinets
    • 8.1.2. ELISA Instruments
    • 8.1.3. PCR Instruments
  • 8.2. Reagents & Kits
    • 8.2.1. Culture Media
    • 8.2.2. ELISA Reagents & Kits
    • 8.2.3. PCR Reagents & Kits
  • 8.3. Services
    • 8.3.1. Calibration Services
    • 8.3.2. Consulting Services
    • 8.3.3. Validation Services
  • 8.4. Software
    • 8.4.1. Data Management Software
    • 8.4.2. Workflow Automation Software

9. Biological Safety Testing Products & Services Market, by Test

  • 9.1. Bioburden
    • 9.1.1. Plate Count
    • 9.1.2. Rapid Methods
  • 9.2. Endotoxin
    • 9.2.1. LAL Test
    • 9.2.2. rFC Test
  • 9.3. Microbial Identification
    • 9.3.1. MALDI-TOF
    • 9.3.2. PCRBased
  • 9.4. Sterility
    • 9.4.1. Direct Inoculation
    • 9.4.2. Membrane Filtration

10. Biological Safety Testing Products & Services Market, by Technology

  • 10.1. Chromatography
  • 10.2. ELISA
  • 10.3. Mass Spectrometry
  • 10.4. PCR

11. Biological Safety Testing Products & Services Market, by End Use

  • 11.1. Academic & Research
  • 11.2. Biotechnology
  • 11.3. CRO
  • 11.4. Food & Beverage
  • 11.5. Hospitals & Diagnostics
  • 11.6. Pharmaceutical

12. Biological Safety Testing Products & Services Market, by Service Mode

  • 12.1. In House
  • 12.2. Outsourced

13. Biological Safety Testing Products & Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Safety Testing Products & Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Safety Testing Products & Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biological Safety Testing Products & Services Market

17. China Biological Safety Testing Products & Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Asahi Kasei Corporation
  • 18.6. Avance Biosciences Inc.
  • 18.7. BBF Sterilisationsservice GmbH
  • 18.8. BSL Bioservice Scientific Laboratories Munich GmbH
  • 18.9. Charles River Laboratories International, Inc.
  • 18.10. Creative Biogene
  • 18.11. Eurofins Scientific SE
  • 18.12. Labquality Oy
  • 18.13. Lonza Group AG
  • 18.14. Merck KGaA
  • 18.15. North American Science Associates, Inc.
  • 18.16. NuAire, Inc.
  • 18.17. Pace Analytical Services, LLC
  • 18.18. Samsung Biologics
  • 18.19. Sartorius AG
  • 18.20. SGS Societe Generale de Surveillance SA
  • 18.21. Thermo Fisher Scientific Inc.
  • 18.22. Toyobo Co., Ltd.
  • 18.23. UL LLC
  • 18.24. ViruSure GmbH
  • 18.25. WuXi Biologics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOSAFETY CABINETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOSAFETY CABINETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CALIBRATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CALIBRATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CALIBRATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VALIDATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VALIDATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VALIDATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY WORKFLOW AUTOMATION SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY WORKFLOW AUTOMATION SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY WORKFLOW AUTOMATION SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PLATE COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PLATE COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PLATE COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RAPID METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RAPID METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RAPID METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY LAL TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY LAL TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY LAL TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RFC TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RFC TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RFC TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MALDI-TOF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MALDI-TOF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCRBASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCRBASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCRBASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DIRECT INOCULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DIRECT INOCULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DIRECT INOCULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MEMBRANE FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MEMBRANE FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY HOSPITALS & DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY HOSPITALS & DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY HOSPITALS & DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY IN HOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY IN HOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY OUTSOURCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY OUTSOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 262. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KIT